DK2332986T3 - Antistof som binder til H-1 parvovirus - Google Patents
Antistof som binder til H-1 parvovirusInfo
- Publication number
- DK2332986T3 DK2332986T3 DK09015373.5T DK09015373T DK2332986T3 DK 2332986 T3 DK2332986 T3 DK 2332986T3 DK 09015373 T DK09015373 T DK 09015373T DK 2332986 T3 DK2332986 T3 DK 2332986T3
- Authority
- DK
- Denmark
- Prior art keywords
- parvovirus
- binds
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09015373.5A EP2332986B1 (en) | 2009-12-11 | 2009-12-11 | Antibody that binds to H-1 parvovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2332986T3 true DK2332986T3 (da) | 2013-12-16 |
Family
ID=42072902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09015373.5T DK2332986T3 (da) | 2009-12-11 | 2009-12-11 | Antistof som binder til H-1 parvovirus |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8828400B2 (da) |
| EP (2) | EP2332986B1 (da) |
| JP (1) | JP5755239B2 (da) |
| AU (1) | AU2010330349B2 (da) |
| CA (1) | CA2781796C (da) |
| DK (1) | DK2332986T3 (da) |
| ES (1) | ES2438774T3 (da) |
| WO (1) | WO2011069614A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2451844B1 (en) | 2009-07-10 | 2015-04-22 | Innate Pharma | Tlr3 binding agents |
| DK2332986T3 (da) * | 2009-12-11 | 2013-12-16 | Deutsches Krebsforsch | Antistof som binder til H-1 parvovirus |
| WO2013178736A1 (en) | 2012-05-31 | 2013-12-05 | Innate Pharma | Tlr3 binding agents |
| EP3108892A1 (en) * | 2015-06-23 | 2016-12-28 | Deutsches Krebsforschungszentrum | Parvovirus formulation for treating tumors |
| JP6608969B2 (ja) * | 2015-06-23 | 2019-11-20 | ドイッチェス・クレープスフォルシュングスツェントルム | パルボウイルスを大規模生産および精製するための方法 |
| CN109627331B (zh) * | 2019-01-22 | 2022-03-29 | 长春西诺生物科技有限公司 | 一种抗犬细小病毒抗体的重链、轻链可变区及基因工程抗体 |
| AU2020321376A1 (en) | 2019-07-30 | 2022-02-03 | Elanco Us Inc. | Parvovirus antibodies for veterinary use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994010294A1 (en) | 1992-10-23 | 1994-05-11 | New York University | Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
| DK2332986T3 (da) * | 2009-12-11 | 2013-12-16 | Deutsches Krebsforsch | Antistof som binder til H-1 parvovirus |
-
2009
- 2009-12-11 DK DK09015373.5T patent/DK2332986T3/da active
- 2009-12-11 EP EP09015373.5A patent/EP2332986B1/en active Active
- 2009-12-11 ES ES09015373.5T patent/ES2438774T3/es active Active
-
2010
- 2010-12-01 JP JP2012542386A patent/JP5755239B2/ja active Active
- 2010-12-01 EP EP10803562A patent/EP2509998A1/en not_active Withdrawn
- 2010-12-01 CA CA2781796A patent/CA2781796C/en active Active
- 2010-12-01 WO PCT/EP2010/007301 patent/WO2011069614A1/en not_active Ceased
- 2010-12-01 AU AU2010330349A patent/AU2010330349B2/en active Active
- 2010-12-01 US US13/513,502 patent/US8828400B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20130028913A1 (en) | 2013-01-31 |
| ES2438774T3 (es) | 2014-01-20 |
| JP5755239B2 (ja) | 2015-07-29 |
| EP2332986A1 (en) | 2011-06-15 |
| CA2781796C (en) | 2016-02-02 |
| AU2010330349B2 (en) | 2013-09-19 |
| WO2011069614A1 (en) | 2011-06-16 |
| EP2509998A1 (en) | 2012-10-17 |
| US8828400B2 (en) | 2014-09-09 |
| EP2332986B1 (en) | 2013-10-09 |
| AU2010330349A1 (en) | 2012-06-28 |
| JP2013513358A (ja) | 2013-04-22 |
| CA2781796A1 (en) | 2011-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2019004I2 (el) | Τροποποιημενα αντισωματα αντι-ιl-23ρ19 | |
| CY2022012I2 (el) | Anti-ifnar1 αντισωματα me μειωμενη συγγενεια προσδετη fc | |
| CY2019017I1 (el) | Cgrp αντισωματα | |
| BRPI1014262A2 (pt) | anticorpos específicos para caderina-17 | |
| EP2473531A4 (en) | Anti-gitr antibodies | |
| BRPI0907237A2 (pt) | Anticorpo anti-cldn6 | |
| HRP20171011T1 (hr) | ANTI-eMET ANTITIJELO | |
| SMT201700083B (it) | Anticorpi monoclonali | |
| BRPI0923359A2 (pt) | Anticorpos anti-igf | |
| BRPI0907532A2 (pt) | Anticorpos anti-c5ar humanizados | |
| PT2406284T (pt) | Anticorpos anti-bcma | |
| HUE056626T2 (hu) | Antitestkészítmény | |
| BRPI0916973A2 (pt) | anticorpos para ccr2 | |
| IL212175B (en) | Muc1* antibodies | |
| BRPI0906877A2 (pt) | Anticorpos anti-trkb aperfeiçoados | |
| BRPI1011005A2 (pt) | anticorpos anti-epcam | |
| EP2482848A4 (en) | Endoglin antibodies | |
| IL232053B (en) | Antibody formulations | |
| IL229618B (en) | Isolated antibody that binds fcrn | |
| DK3653645T3 (da) | Monoklonal interleukin-31-antistof | |
| BR112013016917A2 (pt) | ligantes que ligam receptor de tgf-beta ii. | |
| BRPI0917204A2 (pt) | variantes estruturais de anticorpos para melhores características terapêuticas | |
| EP2181121A4 (en) | CHIMÄRE ANTIGENE | |
| HUE042898T2 (hu) | Antitestek, amelyek kötnek CSF1R-t | |
| CR20170001A (es) | Anticuerpos anti factor d humanizados |